Meaney named a 2023 Outstanding Reviewer for ACCP’s Pharmacotherapy Journal
By Samantha Rzeszut
Published October 6, 2023
Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, has been named a 2023 Outstanding Reviewer for the American College of Clinical Pharmacy’s (ACCP) Pharmacotherapy Journal.
ACCP’s official journals engage many peer reviewers who evaluate submitted manuscripts and help determine which high-quality articles will be published. The best reviewers provide the highest-quality reviews consistently and in a timely manner.
Meaney was recognized by ACCP as one of 11 outstanding reviewers for 2023. He was also recently named a Fellow of ACCP.
“Serving as a peer reviewer is an incredibly important professional service duty that is traditionally underrecognized,” says Meaney. “It’s a wonderful honor to receive this award. I hope it inspires others in the field to continue providing prompt, focused, and constructive reviews to our pharmacy journals.”
Meaney has reviewed 7 manuscripts in the past 3 years. He will be recognized at the 2023 ACCP Annual Meeting during the Awards and Recognition Ceremony on November 12.
ACCP’s mission is to improve human health by extending the frontiers of clinical pharmacy through strategic initiatives, partnerships, collaborations and alliances.
For over 135 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education and is the No. 1 ranked school of pharmacy in New York State and No. 14 in the United States by U.S. News & World Report.